A detailed history of Trexquant Investment LP transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 116,802 shares of BHC stock, worth $990,480. This represents 0.01% of its overall portfolio holdings.

Number of Shares
116,802
Previous 39,793 193.52%
Holding current value
$990,480
Previous $277,000 243.32%
% of portfolio
0.01%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.22 - $8.26 $401,986 - $636,094
77,009 Added 193.52%
116,802 $951,000
Q2 2024

Aug 13, 2024

BUY
$6.1 - $10.41 $242,737 - $414,245
39,793 New
39,793 $277,000
Q4 2022

Feb 13, 2023

BUY
$6.09 - $7.93 $359,943 - $468,694
59,104 New
59,104 $371,000
Q2 2022

Aug 11, 2022

BUY
$7.06 - $23.63 $1.45 Million - $4.85 Million
205,352 Added 306.42%
272,369 $2.28 Million
Q1 2022

May 13, 2022

BUY
$21.6 - $27.79 $1.45 Million - $1.86 Million
67,017 New
67,017 $1.53 Million
Q4 2021

Feb 14, 2022

SELL
$23.0 - $29.01 $1.04 Million - $1.31 Million
-45,069 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$25.04 - $30.06 $1.13 Million - $1.35 Million
45,069 New
45,069 $1.26 Million
Q1 2021

May 13, 2021

SELL
$21.37 - $34.38 $543,973 - $875,142
-25,455 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$15.31 - $21.12 $389,716 - $537,609
25,455 New
25,455 $529,000
Q2 2020

Aug 07, 2020

SELL
$13.31 - $20.51 $1.36 Million - $2.09 Million
-102,130 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$12.98 - $30.25 $1.33 Million - $3.09 Million
102,130 New
102,130 $1.58 Million
Q3 2019

Nov 08, 2019

SELL
$20.88 - $25.66 $1.42 Million - $1.74 Million
-67,881 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$20.52 - $26.45 $1.39 Million - $1.8 Million
67,881 New
67,881 $1.71 Million
Q4 2018

Feb 13, 2019

SELL
$17.64 - $28.32 $1.31 Million - $2.1 Million
-74,184 Closed
0 $0
Q3 2018

Nov 09, 2018

BUY
$20.64 - $25.67 $1.53 Million - $1.9 Million
74,184 New
74,184 $1.9 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $3.07B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.